Abstract:Background: MicroRNAs are noncoding RNAs and have emerged as important regulators in β-cell function. Results: miR-483 is highly expressed in β-cells but expressed at much lower levels in α-cells, and increased miR-483 induces insulin production in β-cells while repressing glucagon production in α-cells. Conclusion: miR-483 has opposite effects in α- and β-cells by targeting SOCS3. Significance: miR-483 is a potential therapeutic target for diabetes. Insulin secreted from pancreatic β-cells and glucagon secreted from pancreatic α-cells are the two major hormones working in the pancreas in an opposing manner to regulate and maintain a normal glucose homeostasis. How microRNAs (miRNAs), a population of non-coding RNAs so far demonstrated to be differentially expressed in various types of cells, regulate gene expression in pancreatic β-cells and its closely associated α-cells is not completely clear. In this study, miRNA profiling was performed and compared between pancreatic β-cells and their partner α-cells. One novel miRNA, miR-483, was identified for its highly differential expression in pancreatic β-cells when compared to its expression in α-cells. Overexpression of miR-483 in β-cells increased insulin transcription and secretion by targeting SOCS3, a member of suppressor of cytokine signaling family. In contrast, overexpression of miR-483 decreased glucagon transcription and secretion in α-cells. Moreover, overexpressed miR-483 protected against proinflammatory cytokine-induced apoptosis in β-cells. This correlates with a higher expression level of miR-483 and the expanded β-cell mass observed in the islets of prediabetic db/db mice. Together, our data suggest that miR-483 has opposite effects in α- and β-cells by targeting SOCS3, and the imbalance of miR-483 and its targets may play a crucial role in diabetes pathogenesis.

MicroRNA-24/MODY Gene Regulatory Pathway Mediates Pancreatic Β-Cell Dysfunction

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

The miR-203/ZBTB20/MAFA Axis Orchestrates Pancreatic β-Cell Maturation and Identity During Weaning and Diabetes

MicroRNA-26a Regulates Insulin Sensitivity and Metabolism of Glucose and Lipids.

Mir-101A and Mir-30B Contribute to Inflammatory Cytokine-Mediated Β-Cell Dysfunction

Obesity-induced overexpression of miR-802 impairs insulin transcription and secretion

MicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes

Obesity-induced upregulation of miR-483-5p impairs the function and identity of pancreatic β-cells

Microrna-503 Contribute to Pancreatic Beta Cell Dysfunction by Targeting the Mtor Pathway in Gestational Diabetes Mellitus.

Expression of miRNA-29 in Pancreatic β Cells Promotes Inflammation and Diabetes via TRAF3

Pancreatic Β Cell Microrna-26A Alleviates Type 2 Diabetes by Improving Peripheral Insulin Sensitivity and Preserving Β Cell Function

Maternal Low Protein Isocaloric Diet Suppresses Pancreatic β-Cell Proliferation in Mouse Offspring via miR-15b.

Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic Β- and Α-Cells

Microrna-19b Downregulates Insulin 1 Through Targeting Transcription Factor Neurod1

Obesity-Induced miR-455 Upregulation Promotes Adaptive Pancreatic β-Cell Proliferation Through the CPEB1/CDKN1B Pathway

Obesity-Induced Regulator of Calcineurin 1 Overexpression Leads to Β-Cell Failure Through Mitophagy Pathway Inhibition

Dmso_a_335088 93..102

MiR-221/222 inhibit insulin production of pancreatic β-cells in mice.

Thioredoxin-interacting protein regulates insulin transcription through microRNA-204

Insulin Secretory Granules Release Exosomal miR-503 to Promote Insulin Resistance and β-Cell Senescence

Obesity-Induced <i>miR-455</i> Upregulation Promotes Adaptive Pancreatic -Cell Proliferation Through the CPEB1/CDKN1B Pathway